Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

5 days ago 3
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

Related

Gold prices hit 1-mth low with US-China trade progress, econ. data in focus

Gold prices hit 1-mth low with US-China trade progress, econ...

2 hours ago 1
Geely Automobile's Q1 net profit triples on record sales

Geely Automobile's Q1 net profit triples on record sales

2 hours ago 1
Deutsche Konsum H1 2024/2025 slides: FFO plunges 51% amid major restructuring

Deutsche Konsum H1 2024/2025 slides: FFO plunges 51% amid ma...

2 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

1. cate blanchett
2. jim carrey
3. nhl bracket
4. the chi
5. progressive insurance
6. nathaniel radimak
7. tiffany haddish
8. wordle hint may 14
9. tyler ferguson
10. green day

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

1 month ago 138
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

1 month ago 108
Stanford 2025 AI Index Reveals Surge in Adoption, Investment, and Global Impact as Trust and Regulation Lag Behind

Stanford 2025 AI Index Reveals Surge in Adoption, Investment...

1 month ago 94
Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge Sours Investor Sentiment

Bitcoin Slips With XRP, ADA as Nvidia's Massive $5.5B Charge...

4 weeks ago 93
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

1 month ago 92
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved